Fiscal impact reports (FIRs) are prepared by the Legislative Finance Committee (LFC) for standing finance
committees of the NM Legislature. The LFC does not assume responsibility for the accuracy of these reports
if they are used for other purposes.
Current FIRs (in HTML & Adobe PDF formats) are a vailable on the NM Legislative Website (legis.state.nm.us).
Adobe PDF versions include all attachments, whereas HTML versions may not. Previously issued FIRs and
attachments may be obtained from the LFC in Suite 101 of the State Capitol Building North.
F I S C A L I M P A C T R E P O R T
SPONSOR Ortiz y Pino
ORIGINAL DATE
LAST UPDATED
01/31/07
02/09/07 HB
SHORT TITLE Lynn and Erin Compassionate Use Act
SB 238/aSJC/aSFl/aHFl
ANALYST Hanika Ortiz
ESTIMATED ADDITIONAL OPERATING BUDGET IMPACT (dollars in thousands)
FY07
FY08
FY09 3 Year
Total Cost
Recurring
or Non-Rec
Fund
Affected
Total
$115.0
Recurring General
Fund
(Parenthesis ( ) Indicate Expenditure Decreases)
SOURCES OF INFORMATION
LFC Files
Responses Received From
Department of Health (DOH)
Regulation and Licensing Department (RLD)
Attorney General’s Office (AGO)
Public Defender’s Department (PDD)
Corrections Department (CD)
Health Policy Commission (HPC)
Aging and Long Term Services Department (ALTSD)
SUMMARY
Synopsis of HFl Amendment
The House Floor Amendment provides that locations for medical cannabis distribution are not to
be located within three hundred feet of any school, church or day care center.
Synopsis of SFl Amendment
The Senate Floor Amendment clarifies that any admission into hospice care in accordance with
DOH rules will qualify for the medicinal use of marijuana to alleviate symptoms.
Synopsis of SJC Amendment
The Senate Judiciary Committee Amendment allows the patient or caregiver not in possession of
a registry identification card, be given an opportunity to produce such card before any arrest is
made. The Amendment also removes the requirement that a practitioner is not required to ensure
a patient or caregiver is holding a temporary certificate prior to recommending the medical use
pg_0002
Senate Bill 238/aSJC/aSF1/aHFl – Page
2
of cannabis pursuant to the Act.
Synopsis of Original Bill
Senate Bill 238 enacts the new Lynn and Erin Compassionate Use Act which authorizes the use
of marijuana by New Mexico adult residents in the treatment of various “debilitating medical
conditions" that are certified by a physician and approved by an advisory board appointed by the
Secretary of Health. DOH is required to establish rules by October 1, 2007 for the medical use of
marijuana and the issuance of appropriate identification cards.
The bill permits prosecution of a certified patient who is driving while under the influence of
marijuana, using marijuana in a school bus or on school grounds, at a place of employment or
and in public parks and recreation areas, etc.
The bill exempts patients, patients’ primary caregivers, licensed physicians and licensed
producers from arrest or prosecution under state law for manufacturing or possession of
marijuana if acting within the program.
The bill exempts any property used in connection with the medical use of marijuana from civil
forfeiture. The bill permits both civil and criminal prosecution of licensed producers under state
law who sell, distribute, dispense or transfer marijuana to uncertified persons or who obtain or
transport marijuana outside of New Mexico.
Senate Bill 238 also amends provisions within 30-31-6 Schedule I and 30-31-7 Schedule II of the
Controlled Substances Act by expanding on the exclusion criteria for qualified patients under the
Lyn and Erin Compassionate Use Act.
FISCAL IMPLICATIONS
There is no appropriation associated with this bill. However, there would be an estimated
$115,000 in costs to DOH to implement this program. Estimated costs for the administration of
the program include 1)Advisory Board per diem and travel, $5,000; 2) Program Manager and
Clerk salary and benefits, $100,000; and 3) Annual Operating Overhead for 2 staff, $10,000.
The courts report there will be a minimal administrative cost for statewide update, distribution
and documentation of statutory changes. Any additional fiscal impact on the judiciary would be
proportional to the enforcement of this law and commenced prosecutions. New laws,
amendments to existing laws and new hearings have the potential to increase caseloads in the
courts, thus requiring additional resources to handle the increase.
SIGNIFICANT ISSUES
The growing, distribution and use of cannabis will still be subject to federal laws and code. AGO
states it is clear that any state statute permitting the use of marijuana for medical purposes
authorizes acts that are clearly unlawful under the federal Controlled Substances Act. Given past
enforcement by the federal government, it seems very likely that persons acting under a program
adopted pursuant to this bill will be subject to federal prosecution.
Ago further comments that until such time as the U. S. Attorney General or the Congress make
pg_0003
Senate Bill 238/aSJC/aSF1/aHFl – Page
3
possession of medical marijuana lawful under federal law, a contrary state law gambles with the
personal liberty of those who use medical marijuana as authorized by state law but that still
subjects them to criminal prosecution under federal law.
PERFORMANCE IMPLICATIONS
The AGO further reports that the bill fails to address the issue of interstate transport of marijuana
by certified patients or their primary caregivers.
The Board of Pharmacy will not be involved in the licensure of the producer or he distribution
settings designated by DOH. Board of Pharmacy laws and rules are tied specifically to the
federal requirements for licensure.
The Courts report that preventing the introduction of marijuana for inmates into the institution by
visitors who may legally have it in their possession may strain the resources of prisons. This bill
places a substantial burden on the staff of correctional institutions to determine which visitors
who may test positive with an ion scan are legally able to possess marijuana
.
ADMINISTRATIVE IMPLICATIONS
The bill does not limit the use of marijuana by qualified individuals except for public areas, work
place of the patient or caregiver, school bus, public vehicle, and school grounds. The Act allows
primary caregivers to care for qualified patients and possess the patient’s adequate supply.
Qualified patients may be residing in Licensed Nursing Homes, Boarding Homes, Residential
Care Facilities, Hospice, Home Health Care Agencies, and even Correctional/Detention
Facilities.
TECHNICAL ISSUES
RLD reports that the term dispensing is used in context with “licensed producer" in the bill.
Dispense is defined in the Pharmacy Act as: “dispense" means the evaluation and
implementation of a prescription, including the preparation and delivery of a drug or device to a
patient or patient’s agent in a suitable container appropriately labeled for subsequent
administration to or use by a patient. The Compassionate Use Act does not include the
requirement for a prescription. The licensed producers, licensed by D.O.H., will actually be
distributing
the marijuana to qualified individuals upon the “written certification" of a licensed
practitioner which is a signed statement in the patient’s record that, in the practitioner’s
professional opinion, the patient has a debilitating medical condition.
OTHER SUBSTANTIVE ISSUES
DOH reports severe chronic pain, anorexia, and spasticity cause significant suffering among
certain people living with cancer, HIV/AIDS, and neuromuscular diseases, including multiple
sclerosis and spinal cord injury. There are approximately 6,553 New Mexicans are diagnosed
with cancer each year, approximately 2,775 cancer patients die each year, and approximately
4,550 New Mexicans are currently living with HIV/AIDS. In some instances, the suffering
associated with symptoms cannot be adequately controlled by the use of available prescription
medications or the side effects of the prescription medications are intolerable. Many patients
have found that these symptoms are well controlled by the use of medical cannabis when relief is
not provided by prescription medications, and scientific evidence provides reasonable support for
pg_0004
Senate Bill 238/aSJC/aSF1/aHFl – Page
4
the contention that cannabis can play a therapeutic role in the treatment of these serious medical
conditions.
ALTSD reports that the American Association of Retired Persons (AARP) conducted a national
medical marijuana poll in November 2004. The results of this poll indicate that nearly 75% of
older Americans support providing access to medical marijuana.
A New Mexico Policy Reform Study conducted in 2001 found that 81% of New Mexico voters
support making medical marijuana available to seriously or terminally ill patients in order to
alleviate their pain and suffering from illnesses such as cancer, AIDS, and multiple sclerosis.
HPC reports that since 1996, eleven states have legalized medical marijuana use: Alaska,
Arizona, California, Colorado, Hawaii, Maine, Nevada, Oregon, Rhode Island, Vermont, and
Washington. Eight of the eleven did so through the initiative process, Hawaii's law was enacted
by the legislature and signed by the governor in 2000, Vermont's was enacted by the legislature
and passed into law without the governor's signature in May 2004, and Rhode Island's was
enacted overriding the governor's veto in January 2006.
The most frequently specified illnesses covered in other states under medical marijuana laws are:
cancer (21 states), glaucoma (19 states), pain/chronic illness (8 states), and HIV/AIDS (7 states).
Seven states enacted laws that apply to all conditions and four states enacted their laws after a
1999 Institute of Medicine report advocated the efficacy of medicinal cannabis to relieve some
symptoms for some people. Four states do not specify any illnesses or symptoms to which their
statutes apply. (RAND Drug Policy Center, 2003)
Despite state legalization of medical marijuana, on June 6, 2005, the US Supreme Court ruled 6
to 3 that the federal government can continue arresting patients who use medical marijuana
legally under their state laws.
ALTERNATIVES
RLD suggests reenacting the Controlled Substances Therapeutic Research Act. The Drug
Enforcement Administration typically has allowed/licensed practitioners (including facilities)
conduct research with any substance listed in Schedule I through V of the Federal Act. The
University of NM Health Sciences at one time was licensed by the DEA and the NM Board of
Pharmacy to conduct therapeutic research under the Controlled Substances Therapeutic Research
Act. That program was discontinued. This new Act will not qualify as research under the federal
code and the possession or distribution of the cannabis would be subject to federal law.
Conviction under federal law could subject the practitioner to disciplinary action in this state and
others where they are licensed.
WHAT WILL BE THE CONSEQUENCES OF NOT ENACTING THIS BILL
State laws that make possession, use or distribution of marijuana a crime will remain in effect,
permitting state prosecution for such acts regardless of medical use.
pg_0005
Senate Bill 238/aSJC/aSF1/aHFl – Page
5
AMENDMENTS
DOH believes more time is needed to promulgate program rules and regulations to implement
this Act. On Page 9, line 1 after “No later than" delete the words “October 1, 2007" and replace
with, “January 1, 2008".
On Page 7, Section 6, include “a representative of the New Mexico Board of Pharmacy."
Page 7, under Section 5, add the following to A. (3)(e) “on the grounds of any state prison, and at
any publicly-operated and privately-operated correctional facility where the corrections
department is housing any of its prisoners". The Courts believe this amendment is needed to
prevent visitors and members of the public from possessing or using cannabis when they enter
the grounds of any state owned and operated prison, any privately-operated prison (such as in
Santa Rosa and Hobbs) where the Department houses its prisoners, and any publicly-operated
correctional facility (such as the Santa Fe County Detention Center) where the Department
houses its prisoners.
AHO/nt